Skip to content

New York · Nonprofit

PANCREATIC CANCER NORTH AMERICA INC

PANCREATIC CANCER NORTH AMERICA INC (New York) receives grants from 2 organizations whose IRS filings report $59,694 to it, the largest being AMERICAN ONLINE GIVING FOUNDATION INC ($59,494). 1 of them have funded it in more than one year, and 100% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.

Revenue FY2025
$316k
Funders on record
2
Grants received
$60k
Net assets
$42k
1/2 repeat funders
01What it does

What Pancreatic Cancer North America Inc does

Mission

Pancreatic Cancer North America, Inc. aims to fundamentally change the experience of pancreatic cancer for patients and their families, and redefine it from a death sentence to a survivable cancer. We focus on accelerating research, expanding our programs and supports while increasing awareness and visibility of pancreatic cancer.

As stated on its FY2025 Form 990.

Programs

  1. Pancreatic Cancer North America, Inc. provided a research grant totaling $200,000 to The University of Texas MD Anderson Cancer Center in support of the 'Multi-omic early detection of pancreatic cancer' research study. This research integrates two powerful tools: blood-based biomarkers and AI-driven imaging analysis of standard CT scans. Together, they create one of the first risk-weighted, dual modality precision screening models for pancreatic cancer--capable of identifying the earliest biological and structural signs of disease, years before symptoms appear. These signals, invisible to the human eye, could unlock the chance to intervene when the disease is still curable.

    $200,000 spentof which $200,000 as grants
    93% of program spending
  2. Pancreatic Cancer North America continued its commitment to raising awareness of pancreatic cancer and advocating for greater supports, by working with healthcare professionals, allied organizations and in particular during World Pancreatic Cancer Day.

    $16,153 spent
    7% of program spending
  3. Other program services, not described on the e-filed return.

    $0 spent
    0% of program spending

The 3 programs described on its FY2025 Form 990, listed largest first by expense. Program spending in total: $216,153.

02The organization over time

The organization over time

Each line starts at 100 in 2021, so what you read is the shape rather than the size: 150 means half as much again as 2021, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.

100 = 20212021 Revenue 100 ($254k) Expenses 100 ($116k) Net assets 100 ($138k)2022 Revenue 88 ($223k) Expenses 220 ($256k) Net assets 77 ($106k)2023 Revenue 55 ($141k) Expenses 130 ($151k) Net assets 69 ($96k)2024 Revenue 51 ($129k) Expenses 144 ($167k) Net assets 42 ($58k)2025 Revenue 124 ($316k) Expenses 285 ($331k) Net assets 31 ($42k)
20212022202320242025
Revenue (124)Expenses (285)Net assets (31)Peer revenue range

Balance sheet

Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2023 to 2024, from $96k to $69k (−28%).

$138k
$117k
$96k
$69k
$70k
20212022202320242025
Total assetsTotal liabilities

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

2021
2022
2023
2024
2025
ContributionsProgram revenueInvestmentOther

100% of PANCREATIC CANCER NORTH AMERICA INC’s revenue is contributions — more reliant on donations than three-quarters of its peers (82% for the typical peer).

This organization
Typical peer · 14,893 orgs

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 4 of the last 5 reported years ran a deficit.

$138k
’21
−$32k
’22
−$10k
’23
−$39k
’24
−$15k
’25
0.4
months of
reserve

Leadership and staff

The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.

Board chair

Jonathan Paul

Board Chair

As listed on its FY2025 Form 990.

20212022202320242025
Listed57796
Joined·+4+0+4+1
No longer listed·2024
03Who funds it

Who funds it, year by year

Grant support over time, funder by funder — shade shows the grant size each year.

Funder
'24*
'25*
'26*
total
funders
2
1
1

1 of 2 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 100% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.

From the IRS filings of PANCREATIC CANCER NORTH AMERICA INC’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How concentrated its funding is

PANCREATIC CANCER NORTH AMERICA INC leans on a few funders — its largest provides 100% of grant income and the top three 100%; half comes from just 1 funder.

the vertical line marks half of all grant income — 1 funder to its left

100% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund PANCREATIC CANCER NORTH AMERICA INC.

100%
largest funder
100%
top three
~1
effective funders

“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

Where its funders are

100% of PANCREATIC CANCER NORTH AMERICA INC's grant income arrives through donor-advised or pass-through sponsors, whose addresses record where the money is held rather than where the donor is. Of the $200 that is directly attributable, 100% of it comes from New York funders.

NY

Funder states come from each funder’s own filing. $59k arriving through sponsors registered in 1 state is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

04Its place in the field

Against its field

PANCREATIC CANCER NORTH AMERICA INC's revenue grew 24% between 2021 and 2025.

Operating margin−5% · below the median
Months of reserve0.4mo · bottom quartile
Revenue growth (annualized)6% · below the median

this organization peer median middle 50% of peers· 7,883 health nonprofits $100k–$1M, FY2025

Organizations like PANCREATIC CANCER NORTH AMERICA INC

Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.

In New York

Nationally

05Profile & governance

Read directly from this organization’s own Form 990, as neutral context.

Where the money goes

65% of spending goes to programs.

Program 65%Management 13%Fundraising 21%

Governance

5
board members
100%
independent
✓Conflict-of-interest policy–Whistleblower policy–Document retention✓Board reviewed the 990–Audited financials

Public support

100%

Share of support from the public (Schedule A) — the basis for its public-charity status.

Footprint & structure

Files a return copy in 7 states

IL
NY
MA
CA
DE
TX
FL

Part of a family of 1 related entity

  • Pancreatic Cancer Canada · exempt

Screen this organization

A dated, signed PDF of the compliance screen for PANCREATIC CANCER NORTH AMERICA INC: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.

A paid feature, included from the $75 plan up. Sign in to download.

Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf

Questions and answers

Who funds PANCREATIC CANCER NORTH AMERICA INC?
PANCREATIC CANCER NORTH AMERICA INC (New York) receives grants from 2 organizations whose IRS filings report $59,694 to it, the largest being AMERICAN ONLINE GIVING FOUNDATION INC ($59,494). 1 of them have funded it in more than one year, and 100% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
How many funders does PANCREATIC CANCER NORTH AMERICA INC have?
IRS filings report 2 organizations giving $59,694 in grants to PANCREATIC CANCER NORTH AMERICA INC, 1 of which have funded it in more than one year.
Who is the largest funder of PANCREATIC CANCER NORTH AMERICA INC?
AMERICAN ONLINE GIVING FOUNDATION INC is the largest funder on record, with $59,494 in grants. The full list of funders is on this page.
How can an organization like PANCREATIC CANCER NORTH AMERICA INC find more funders?
Start with the funders already giving here, then look at the foundations that back similar organizations in New York. The funding by cause and by state pages list the largest funders for a given area and how to approach them.

These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2021–2025), and the filings of 2 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing